Results of breast cancer drug trials are regularly spun to conceal bias and make the drugs seem more effective or less toxic than they really are.
Advertisement
The Scientist
Most Recent
Affordable diagnostic tests tackle the world’s most pressing health problems.
Two new studies claim that a shoddy test may have caused Alzheimer’s drugs to fail in clinical trials.
The commonly abused hallucinogen shows promise in extinguishing fear in rats, pointing to possible benefits for patients with post-traumatic stress disorder.
The most high-tech laboratory in the history of the Olympic Games is prepared to begin athlete testing in London.
Page 1 of 1
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
